Ironwood Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Ironwood Pharmaceuticals

16/02/2023 14:32

* Ironwood Pharmaceuticals Inc  IRWD.OQ  reported quarterly
adjusted earnings of 27 cents​​ per share for the quarter ended
in December. The mean expectation of five analysts for the
quarter was for earnings of 27 cents per share.
    * Revenue fell 8.5% to $107.20 million from a year ago;
analysts
expected $110.84 million. 
    * Ironwood Pharmaceuticals Inc's reported EPS for the
quarter was
27 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10.7%
in the last three months.​ 
    * In the last 30 days four analysts negatively revised
earnings
estimates 
    * Ironwood Pharmaceuticals Inc shares had fallen by 9.6%
this
quarter.
    * The company reported quarterly net income of $48.87
million.
    * Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is $13.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
16 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.27           0.27           Met
 Sep. 30 2022      0.27           0.28           Beat
 Jun. 30 2022      0.30           0.21           Missed
 Mar. 31 2022      0.26           0.21           Missed